![An Allopurinol-Controlled, Randomized, Double-Dummy, Double-Blind, Parallel Between-Group, Comparative Study of Febuxostat (TMX-67), a Non-Purine-Selective Inhibitor of Xanthine Oxidase, in Patients With Hyperuricemia Including Those With Gout in Japan]()
An Allopurinol-Controlled, Randomized, Double-Dummy, Double-Blind, Parallel Between-Group, Comparative Study of Febuxostat (TMX-67), a Non-Purine-Selective Inhibitor of Xanthine Oxidase, in Patients With Hyperuricemia Including Those With Gout in JapanKamatani, Naoyuki; Fujimori, Shin; Hada, Toshikazu; Hosoya, Tatsuo; Kohri, Kenjiro; Nakamura, Toshitaka; Ueda, Takanori; Yamamoto, Tetsuya; Yamanaka, Hisashi; Matsuzawa, Yuji · Journal of Clinical Rheumatology · 2011